<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/teva-tev-408-phase-2a-celiac-disease-primary-endpoint</loc>
    <lastmod>2026-09-02T22:01:05+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>Teva’s TEV-408 Meets Primary Endpoint in Phase 2a Celiac Study</news:title>
      <news:keywords>Teva</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml-eu.globenewswire.com/Resource/Download/2392ceaa-b1f3-44a8-bd7e-4c775053e093</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/evotec-plectonic-research-collaboration-t-cell-engager-solid-tumors</loc>
    <lastmod>2026-09-02T13:41:13+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>Evotec Partners With Plectonic to Advance T Cell Engager Platform</news:title>
      <news:keywords>Evotec</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2a44d9e7-a3fb-40eb-a603-11aff3b65cf7/1ce08868-891a-4be1-9a53-231991e8178c.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/nicox-extends-cash-runway-q1-2028-ncx-470-pdufa</loc>
    <lastmod>2026-09-02T13:39:46+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>Nicox Extends Cash Runway to Q1 2028 Ahead of NCX 470 PDUFA Date</news:title>
      <news:keywords>Nicox</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2a44d9e7-a3fb-40eb-a603-11aff3b65cf7/7ccbb5cb-0d59-4f5e-9484-8c5a9cc5da57.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/india-glycols-demerges-biopharma-ennature-bio-pharma</loc>
    <lastmod>2026-09-02T12:45:54+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>India Glycols Spins Off Biopharma Unit as Ennature Bio Pharma</news:title>
      <news:keywords>Biopharma</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c50fdc99-abaf-4b13-a44a-995a9fc85710/d3b8a6b2-7814-4f7d-8116-392ef629c0bc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cber-ngs-workshop-adventitious-agent-detection-biologics-2026</loc>
    <lastmod>2026-09-02T12:43:26+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>FDA CBER Convenes NGS Workshop on Biologics Detection Standards</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c50fdc99-abaf-4b13-a44a-995a9fc85710/a7f63bff-764e-4e14-9d50-9aabe626f726.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/telix-bipass-enrollment-complete-fda-nda-pathway-68ga-psma-pet</loc>
    <lastmod>2026-09-02T12:43:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>Telix Completes BiPASS Enrollment, Secures FDA NDA Path</news:title>
      <news:keywords>Telix Pharmaceuticals</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://s.w.org/images/core/emoji/17.0.2/72x72/2122.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/atyr-pharma-fda-protocol-response-efzofitimod-phase-3-sarcoidosis-2026</loc>
    <lastmod>2026-09-02T12:43:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-02T00:00:00+05:30</news:publication_date>
      <news:title>aTyr Expects FDA Response on Phase 3 Sarcoidosis Study</news:title>
      <news:keywords>aTyr</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/132f33f3-c7e8-4d5b-abb0-040fb069a239/a216f6d4-6263-454d-859e-0bed167cc9fc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/elevar-therapeutics-cares-310-age-subgroup-camrelizumab-rivoceranib-ilca-2026</loc>
    <lastmod>2026-09-01T22:11:39+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>Elevar Presents CARES-310 Age Data at ILCA 2026</news:title>
      <news:keywords>Elevar</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/2665e50f-c974-42bc-a8b1-5655784657da.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/emcure-pharmaceuticals-appoints-anshuman-rai-associate-vice-president</loc>
    <lastmod>2026-09-01T22:13:30+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>Emcure Pharmaceuticals Appoints Anshuman Rai as VP</news:title>
      <news:keywords>Emcure</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/77d8e606-d545-4814-b279-b4d5ac52f1bc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cdt-equity-appoints-james-bligh-chief-executive-officer</loc>
    <lastmod>2026-09-01T22:14:45+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>CDT Equity Names Co-Founder James Bligh as CEO</news:title>
      <news:keywords>CDT</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/4b3ea66c-40de-482a-9026-a4087d19b687.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/reliance-life-sciences-fda-warning-letter-microbiology-lab-falsification-2026</loc>
    <lastmod>2026-09-01T22:16:15+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>FDA Warns Reliance Life Sciences Over Falsified Lab Records</news:title>
      <news:keywords>Reliance</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/c45f7415-08f9-4456-bda1-2d682a2ea070.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-dscsa-portal-requirements-traceability-obligations-distributors-manufacturers</loc>
    <lastmod>2026-09-01T22:26:54+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>FDA Tightens DSCSA Portal Rules for Drug Traceability</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/d3907e8c-1c65-4c0b-9f4b-1d920244dadd.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fibrobiologics-secures-us-patent-fibroblast-conditioned-media-degenerative-disc-disease</loc>
    <lastmod>2026-09-01T22:19:48+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>FibroBiologics Secures U.S. Patent for Disc Disease Therapy</news:title>
      <news:keywords>FibroBiologics</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/e5bdf8bb-eb96-4a80-8d63-06ebdde7b928.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/olympia-pharmaceuticals-launches-gonadorelin-injection-503b-mens-hormone-portfolio</loc>
    <lastmod>2026-09-01T22:17:59+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>Olympia Launches Gonadorelin Injection in 503B Portfolio</news:title>
      <news:keywords>Olympia</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/5b3c86da-e5d9-4e3b-9589-bd95dce20534.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/peptide-partners-llc-fda-warning-letter-unapproved-injectable-peptides-2026</loc>
    <lastmod>2026-09-01T22:24:11+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>FDA Warns Peptide Partners Over Seven Unapproved Injectable Peptides</news:title>
      <news:keywords>Peptide</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/7e24f2fc-adc8-4c40-a897-d2f1ccbeb3c5.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-draft-guidance-ai-model-credibility-drug-biologics-submissions</loc>
    <lastmod>2026-09-01T22:21:51+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>FDA Issues Draft Guidance on AI Model Credibility</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f0e22935-55a8-45f6-bd13-7555f7e8e482/0090f6fb-7e02-45e5-9267-74542726efbe.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ema-nams-voluntary-data-submission-pilot-non-animal-testing-europe</loc>
    <lastmod>2026-09-01T22:10:07+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:00:00+05:30</news:publication_date>
      <news:title>EMA Launches Pilot to Advance Non-Animal Testing Data</news:title>
      <news:keywords>EMA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4e1844be-d5a2-428a-9972-ad89266aad28/c0357bee-61ff-472d-b983-9e1b77ec19eb.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/cdmo-live-americas-2026-brings-the-biopharma-outsourcing-community</loc>
    <lastmod>2026-09-01T13:17:13+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T13:17:11+05:30</news:publication_date>
      <news:title>CDMO Live Americas 2026  brings the Biopharma Outsourcing Community</news:title>
      <news:keywords>CDMO Live Americas 2026, 
pharmaceutical outsourcing, 
biopharma outsourcing,</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cdmo_live_americas_feature(1)20260901124923.png</image:loc>
    </image:image>
  </url>
</urlset>